e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
New targets and modalities for the treatment of asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study
Veit Erpenbeck (Basel, Switzerland), Veit J. Erpenbeck, Todor A. Popov, S. David Miller, Steven F. Weinstein, Sheldon Spector, Baldur Magnusson, Wande Osuntokun, Paul Goldsmith, Markus Weiss, Jutta Beier
Source:
International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Session:
New targets and modalities for the treatment of asthma and COPD
Session type:
Poster Discussion
Number:
2125
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Veit Erpenbeck (Basel, Switzerland), Veit J. Erpenbeck, Todor A. Popov, S. David Miller, Steven F. Weinstein, Sheldon Spector, Baldur Magnusson, Wande Osuntokun, Paul Goldsmith, Markus Weiss, Jutta Beier. QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study. Eur Respir J 2015; 46: Suppl. 59, 2125
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Montelukast improves air trapping, not airway remodeling, in moderate-to-severe patients with asthma: A pilot tudy
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
An extensive function evaluation in severe asthma with airflow limitation
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Characterisation of asthma patients with persistent airflow obstruction
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Comparison of clinical features of severe persistent asthma and refractory asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
LATE-BREAKING ABSTRACT: Benralizumab reduces exacerbations in severe, uncontrolled asthma: Results of the phase III CALIMA trial
Source: International Congress 2016 – Late-breaking topics in airways disease
Year: 2016
LATE-BREAKING ABSTRACT: Benralizumab for mild to moderate, persistent asthma: The BISE phase III study
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
Tiotropium for uncontrolled asthma (a meta-analysis)
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
LATE-BREAKING ABSTRACT: Benralizumab provides significant improvements for patients with severe, uncontrolled asthma: SIROCCO Phase III results
Source: International Congress 2016 – Novel strategies on COPD and asthma management
Year: 2016
Is sustained control of severe asthma possible? A composite score to assess 1-year of asthma control
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Managing asthma patients: which outcomes matter?
Source: Eur Respir Rev 2008; 17: 53-61
Year: 2008
Additive layer manufacturing of physiologically realistic patient specific airway models for study of flow modifications in asthma and COPD
Source: Annual Congress 2013 –Functional imaging
Year: 2013
T
H
2 specific biomarker profile determines steroid responsiveness in severe asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT)
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Higher burden of asthma symptoms and increased blood eosinophils in ACOS
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Predictors of long-term lung function decline in adult-onset asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept